- +1 551 333 1547
- +44 2070 979277
- live:skype_chat
Active Pharmaceutical Ingredient Comprehensive Study by Type (Innovative, Generic), Application (Chemical, Deodorant, Others) Players and Region - Global Market Outlook to 2027
Active Pharmaceutical Ingredient Market by XX Submarkets | Forecast Years 2022-2027
Industry Background:
Active pharmaceutical ingredients (APIs) are good quality ingredients that are essential for the manufacture of effective & safe medicines. High prevalence & incidence rates of cancers, dental carries, cardiovascular diseases, back pain, & periodontal diseases drive the growth of the market. Demand for low-cost medicines & increase in the number of ANDA filings are fueling the growth of global active pharmaceutical ingredients market. Patent expiration of prominent drugs, favorable government initiatives, regional penetration & increasing aged population are some of the factors that are driving the market growth. Strict validation & safety guidelines stated by WHO & fragmented market are the factors that are hampering the growth of API market.This growth is primarily driven by Growing Incidences of Chronic Diseases and Inclination towards Bio-pharmaceuticals products.| Attributes | Details |
|---|---|
| Study Period | 2017-2027 |
| Base Year | 2021 |
| Forecast Period | 2022-2027 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Million) |
| Key Companies in Study | Pfizer, Inc. (United States), Novartis AG (Switzerland), Sanofi (France), Boehringer Ingelheim (Germany), Bristol-Myers Squibb (United States), Teva Pharmaceutical Industries Ltd. (Israel), Eli Lilly and Company (United States), GlaxoSmithKline plc (United Kingdom) and Merck & Co., Inc. (United States) |
| Customization Scope | Avail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility |
Globally, a noticeable market trend is evident Increasing Technological Advancements in API Manufacturing . Major Players, such as Pfizer, Inc. (United States), Novartis AG (Switzerland), Sanofi (France), Boehringer Ingelheim (Germany), Bristol-Myers Squibb (United States), Teva Pharmaceutical Industries Ltd. (Israel), Eli Lilly and Company (United States), GlaxoSmithKline plc (United Kingdom) and Merck & Co., Inc. (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.
Acquisitions and collaborations have been the key growth strategies adopted by players in the recent years. For example, In January 2018, Pfizer entered into a collaboration with Sangamo Therapeutics, Inc. (US) for the development of a potential gene therapy to treat amyotrophic lateral sclerosis (ALS) and in May 2018, Novartis acquired AveXis, a clinical-stage gene therapy company, to develop a gene-based treatment for spinal muscular atrophy.
Market Drivers
- Growing Incidences of Chronic Diseases
- Inclination towards Bio-pharmaceuticals products
Market Trend
- Increasing Technological Advancements in API Manufacturing
- Acceptance of Artificial Intelligence-Based Tools for Drug Discovery
Restraints
- Availability of counterfeit products
- High manufacturing cost
Opportunities
Increasing Healthcare Expenditure and Growing Investments by Pharmaceutical CompaniesAMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.
Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
Against this Challenging Backdrop, Active Pharmaceutical Ingredient Study Sheds Light on
— The Active Pharmaceutical Ingredient Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Active Pharmaceutical Ingredient industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.— Where Active Pharmaceutical Ingredient industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.
Report Objectives / Segmentation Covered
By Type
- Innovative
- Generic
By Application
- Chemical
- Deodorant
- Others
By Regions
- South America
- Brazil
- Argentina
- Rest of South America
- Asia Pacific
- China
- Japan
- India
- South Korea
- Taiwan
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- Italy
- United Kingdom
- Netherlands
- Rest of Europe
- MEA
- Middle East
- Africa
- North America
- United States
- Canada
- Mexico
- 1. Market Overview
- 1.1. Introduction
- 1.2. Scope/Objective of the Study
- 1.2.1. Research Objective
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Growing Incidences of Chronic Diseases
- 3.2.2. Inclination towards Bio-pharmaceuticals products
- 3.3. Market Trends
- 3.3.1. Increasing Technological Advancements in API Manufacturing
- 3.3.2. Acceptance of Artificial Intelligence-Based Tools for Drug Discovery
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 5. Global Active Pharmaceutical Ingredient, by Type, Application and Region (value and price ) (2016-2021)
- 5.1. Introduction
- 5.2. Global Active Pharmaceutical Ingredient (Price)
- 5.2.1. Global Active Pharmaceutical Ingredient by: Type (Price)
- 6. Active Pharmaceutical Ingredient: Manufacturers/Players Analysis
- 6.1. Company Profile
- 6.1.1. Pfizer, Inc. (United States)
- 6.1.1.1. Business Overview
- 6.1.1.2. Products/Services Offerings
- 6.1.1.3. Financial Analysis
- 6.1.1.4. SWOT Analysis
- 6.1.2. Novartis AG (Switzerland)
- 6.1.2.1. Business Overview
- 6.1.2.2. Products/Services Offerings
- 6.1.2.3. Financial Analysis
- 6.1.2.4. SWOT Analysis
- 6.1.3. Sanofi (France)
- 6.1.3.1. Business Overview
- 6.1.3.2. Products/Services Offerings
- 6.1.3.3. Financial Analysis
- 6.1.3.4. SWOT Analysis
- 6.1.4. Boehringer Ingelheim (Germany)
- 6.1.4.1. Business Overview
- 6.1.4.2. Products/Services Offerings
- 6.1.4.3. Financial Analysis
- 6.1.4.4. SWOT Analysis
- 6.1.5. Bristol-Myers Squibb (United States)
- 6.1.5.1. Business Overview
- 6.1.5.2. Products/Services Offerings
- 6.1.5.3. Financial Analysis
- 6.1.5.4. SWOT Analysis
- 6.1.6. Teva Pharmaceutical Industries Ltd. (Israel)
- 6.1.6.1. Business Overview
- 6.1.6.2. Products/Services Offerings
- 6.1.6.3. Financial Analysis
- 6.1.6.4. SWOT Analysis
- 6.1.7. Eli Lilly and Company (United States)
- 6.1.7.1. Business Overview
- 6.1.7.2. Products/Services Offerings
- 6.1.7.3. Financial Analysis
- 6.1.7.4. SWOT Analysis
- 6.1.8. GlaxoSmithKline plc (United Kingdom)
- 6.1.8.1. Business Overview
- 6.1.8.2. Products/Services Offerings
- 6.1.8.3. Financial Analysis
- 6.1.8.4. SWOT Analysis
- 6.1.9. Merck & Co., Inc. (United States)
- 6.1.9.1. Business Overview
- 6.1.9.2. Products/Services Offerings
- 6.1.9.3. Financial Analysis
- 6.1.9.4. SWOT Analysis
- 6.1.1. Pfizer, Inc. (United States)
- 6.1. Company Profile
- 7. Global Active Pharmaceutical Ingredient Sale, by Type, Application and Region (value and price ) (2022-2027)
- 7.1. Introduction
- 7.2. Global Active Pharmaceutical Ingredient (Price)
- 7.2.1. Global Active Pharmaceutical Ingredient by: Type (Price)
- 8. Appendix
- 8.1. Acronyms
- 9. Methodology and Data Source
- 9.1. Methodology/Research Approach
- 9.1.1. Research Programs/Design
- 9.1.2. Market Size Estimation
- 9.1.3. Market Breakdown and Data Triangulation
- 9.2. Data Source
- 9.2.1. Secondary Sources
- 9.2.2. Primary Sources
- 9.3. Disclaimer
- 9.1. Methodology/Research Approach
List of Tables
- Table 1. Active Pharmaceutical Ingredient: by Type(USD/Units)
- Table 2. Company Basic Information, Sales Area and Its Competitors
- Table 3. Company Basic Information, Sales Area and Its Competitors
- Table 4. Company Basic Information, Sales Area and Its Competitors
- Table 5. Company Basic Information, Sales Area and Its Competitors
- Table 6. Company Basic Information, Sales Area and Its Competitors
- Table 7. Company Basic Information, Sales Area and Its Competitors
- Table 8. Company Basic Information, Sales Area and Its Competitors
- Table 9. Company Basic Information, Sales Area and Its Competitors
- Table 10. Company Basic Information, Sales Area and Its Competitors
- Table 11. Active Pharmaceutical Ingredient: by Type(USD/Units)
- Table 12. Research Programs/Design for This Report
- Table 13. Key Data Information from Secondary Sources
- Table 14. Key Data Information from Primary Sources
List of Figures
- Figure 1. Porters Five Forces
- Figure 2. Supply/Value Chain
- Figure 3. PESTEL analysis
- Figure 4. Global Active Pharmaceutical Ingredient: by Type USD/Units (2016-2021)
- Figure 5. Pfizer, Inc. (United States) Revenue, Net Income and Gross profit
- Figure 6. Pfizer, Inc. (United States) Revenue: by Geography 2021
- Figure 7. Novartis AG (Switzerland) Revenue, Net Income and Gross profit
- Figure 8. Novartis AG (Switzerland) Revenue: by Geography 2021
- Figure 9. Sanofi (France) Revenue, Net Income and Gross profit
- Figure 10. Sanofi (France) Revenue: by Geography 2021
- Figure 11. Boehringer Ingelheim (Germany) Revenue, Net Income and Gross profit
- Figure 12. Boehringer Ingelheim (Germany) Revenue: by Geography 2021
- Figure 13. Bristol-Myers Squibb (United States) Revenue, Net Income and Gross profit
- Figure 14. Bristol-Myers Squibb (United States) Revenue: by Geography 2021
- Figure 15. Teva Pharmaceutical Industries Ltd. (Israel) Revenue, Net Income and Gross profit
- Figure 16. Teva Pharmaceutical Industries Ltd. (Israel) Revenue: by Geography 2021
- Figure 17. Eli Lilly and Company (United States) Revenue, Net Income and Gross profit
- Figure 18. Eli Lilly and Company (United States) Revenue: by Geography 2021
- Figure 19. GlaxoSmithKline plc (United Kingdom) Revenue, Net Income and Gross profit
- Figure 20. GlaxoSmithKline plc (United Kingdom) Revenue: by Geography 2021
- Figure 21. Merck & Co., Inc. (United States) Revenue, Net Income and Gross profit
- Figure 22. Merck & Co., Inc. (United States) Revenue: by Geography 2021
- Figure 23. Global Active Pharmaceutical Ingredient: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
- Pfizer, Inc. (United States)
- Novartis AG (Switzerland)
- Sanofi (France)
- Boehringer Ingelheim (Germany)
- Bristol-Myers Squibb (United States)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Eli Lilly and Company (United States)
- GlaxoSmithKline plc (United Kingdom)
- Merck & Co., Inc. (United States)
Additional players considered in the study are as follows:
AbbVie Inc. (United States)
,
F. Hoffmann-La Roche Ltd. (Switzerland)
,
AstraZeneca plc (United Kingdom)
,
,
Select User Access Type
Key Highlights of Report
May 2022
232 Pages
68 Tables
Base Year: 2021
Coverage: 15+ Companies; 18 Countries
Request Sample Pages
Budget constraints? Get in touch with us for special pricing
Check Discount Now
Talk to Our Experts
Want to Customize Study?
"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."
Frequently Asked Questions (FAQ):
Historical year: 2017-2021; Base year: 2021; Forecast period: 2022 to 2027
Companies that are profiled in Global Active Pharmaceutical Ingredient Market are Pfizer, Inc. (United States), Novartis AG (Switzerland), Sanofi (France), Boehringer Ingelheim (Germany), Bristol-Myers Squibb (United States), Teva Pharmaceutical Industries Ltd. (Israel), Eli Lilly and Company (United States), GlaxoSmithKline plc (United Kingdom) and Merck & Co., Inc. (United States) etc.
AMA predicts that United States and United Kingdom Players will contribute to the maximum growth of Global Active Pharmaceutical Ingredient market throughout the forecasted period.